
Major National Heart, Lung, and Blood Institute COPD Research Grant Funding FY 2019
Overview
- Help expand, coordinate, and optimize COPD research efforts
- Improve methods for earliest detection and diagnosis and develop effective strategies for preventing the onset and progression of COPD
- Define and characterize the pathogenesis of COPD heterogeneity
- Develop personalized medicine for COPD based on the pathogenesis and clinical heterogeneity
- Promote research that can lead to strategies that help prevent the onset and progression of COPD and improve the quality of COPD care and management
Activity Description
The National Heart, Lung, and Blood Institute (NHLBI) awards funding to research organizations to implement activities that further the goals and objectives of the COPD National Action Plan. For fiscal year 2019, NHLBI awarded large research grants to three organizations to support their efforts in raising awareness to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD. The organizations funded this cycle include Columbia University Health Sciences; University of California, San Francisco and Wake Forest University Health Sciences.The funded topics are:
• Combined Cardiopulmonary Failure in COPD: SPIROMICS HF;
• Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD;
• Integrated Analysis of Microbial and Genomic data in Obstructive Lung Disease (I AM GOLD) Study